Editorial: Nephrotic Syndrome in Children

Editorial: Nephrotic Syndrome in Children

Bibliographic Details
Main Authors:	Sami A. Sanjad, Tim Ulinski, Bilal Aoun
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-11-01
Series:	Frontiers in Pediatrics
Subjects:	nephrotic syndrome corticosteroids immunosuppressives rituximab mycophenolate mofetil interleukins
Online Access:	https://www.frontiersin.org/articles/10.3389/fped.2021.803923/full

Similar Items

Randomized clinical trial to compare efficacy and safety of repeated courses of rituximab to single-course rituximab followed by maintenance mycophenolate-mofetil in children with steroid dependent nephrotic syndrome
by: Biswanath Basu, et al.
Published: (2020-11-01)

Use of rituximab in pediatric patients with steroidresistant nephrotic syndrome. A single center study
by: Serna-Higuita, Lina María, et al.
Published: (2015-01-01)

Mycophenolate Mofetil in the Treatment of Steroid-Dependent or Frequently Relapsing Nephrotic Syndrome in Children: A Meta-Analysis
by: Xin Xiang, et al.
Published: (2021-06-01)

Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07)
by: Tomoko Horinouchi, et al.
Published: (2018-11-01)

A multicenter, randomized, open-label, comparative, phase IV study to evaluate the efficacy and safety of combined treatment with mycophenolate mofetil and corticosteroids in advanced immunoglobulin A nephropathy
by: Sang Youb Han, et al.
Published: (2022-07-01)

Mycophenolate mofetil versus cyclophosphamide for idiopathic membranous nephropathy; a double blind and randomized clinical trial
by: Fatemeh Hayati, et al.
Published: (2019-04-01)

Effectiveness and safety of mycophenolate mofetil and rituximab combination therapy for immune idiopathic myopathies
by: Corrado Campochiaro, et al.
Published: (2024-04-01)

Mediastinal tuberculous abscess: A rare presentation after renal transplant
by: Sukanto K Das, et al.
Published: (2019-01-01)

Susac syndrome – A Portuguese experience
by: Mariana Portela, et al.
Published: (2023-01-01)

The efficacy of rituximab in treatment of childhood steroid resistant and steroid dependent nephrotic syndrome: a systematic review and Meta-analysis
by: Hamid Mohammadjafar, et al.
Published: (2013-05-01)

The efficacy of rituximab in treatment of childhood steroid resistant and steroid dependent nephrotic syndrome: a systematic review and Meta-analysis
by: Hamid Mohammadjafari, et al.
Published: (2013-05-01)

A Case of Anti-Synthetase Syndrome Successfully Treated with Mycophenolate Mofetil and Rituximab but No Corticosteroids
by: Agnieszka Ewa Sieradzka, et al.
Published: (2022-07-01)

Current and emerging treatment options in the management of lupus
by: Jordan N, et al.
Published: (2016-03-01)

Nephrotic syndrome: what's new, what's hot?
by: Hee Gyung Kang, et al.
Published: (2015-08-01)

Mycophenolate Mofetil;A Review of Indications and Use in a Large Tertiary Hospital
by: Nimeshan Geevasinga, et al.
Published: (2005-12-01)

Clinical experience with mycophenolate mofetil in systemic autoimmune conditions refractory to common immunosuppressive therapies
by: C Bandelier
Published: (2009-01-01)

Pharmacokinetics of mycophenolic acid and its effect on CD4+ and CD8+ T cells after oral administration of mycophenolate mofetil to healthy cats
by: Jennifer E. Slovak, et al.
Published: (2019-09-01)

Corticosteroid response in children with nephrotic syndrome, Amirkola Children Hospital, 1994-2001
by: H Sorkhi, et al.
Published: (2002-07-01)

COVID-19 Pneumonia in Patients with Chronic Myocarditis (HBV-Associated with InfarctLike Debute): Specifics of the Diseases Course, the Role of the Basic Therapy (Part II)
by: O. V. Blagova, et al.
Published: (2020-11-01)

Hypokalemia after rituximab administration in nephrotic syndrome: two case reports
by: Yiyun Song, et al.
Published: (2023-07-01)

Working Towards a Treat-to-Target Protocol in Juvenile Proliferative Lupus Nephritis – A Survey of Pediatric Rheumatologists and Nephrologists in Germany and Austria
by: Kristina Vollbach, et al.
Published: (2022-04-01)

Application and efficacy analysis of rituximab in the treatment of childhood primary nephrotic syndrome in Ningxia
by: Wu Yang, et al.
Published: (2024-02-01)

Case Report: Diagnosis of Myelodysplastic Syndrome in a 72-Year-Old Female With Interstitial Lung Disease
by: Nikoleta Bizymi, et al.
Published: (2021-08-01)

Rituximab Use in the Management of Childhood Nephrotic Syndrome
by: Mahmoud Kallash, et al.
Published: (2019-05-01)

Rituximab therapy for childhood onset idiopathic nephrotic syndrome: experience of a Portuguese tertiary center
by: Rita Gomes, et al.
Published: (2022-10-01)

Rituximab treatment in children with difficult-to-treat nephrotic syndrome
by: Gönül Parmaksız
Published: (2022-06-01)

Rituximab use in the treatment of children with nephrotic syndrome
by: L.I. Vakulenko, et al.
Published: (2022-06-01)

Mycophenolate mofetil and lichen planopilaris: systematic review and meta-analysis
by: Niyaz Mostafa, et al.
Published: (2022-01-01)

Mycophenolate mofetil and atopic dermatitis: systematic review and meta-analysis
by: Kevin Phan, et al.
Published: (2020-11-01)

The association of mycophenolate mofetil and human herpes virus infection
by: Jenny Sung Won Yun, et al.
Published: (2020-01-01)

A comprehensive review of immunosuppressive drugs in pediatric dermatoses: Part II – methotrexate and mycophenolate mofetil
by: Shiti Bose, et al.
Published: (2022-01-01)

The use of immunosuppression in autoimmune hepatitis: A current literature review
by: Angela Cropley, et al.
Published: (2017-03-01)

Clinical case of steroid-dependent nephrotic syndrome in a child
by: Ye. Lagodych, et al.
Published: (2023-06-01)

Mycophenolate Mofetil Versus Prednisone for Induction Therapy in Steroid-Sensitive Idiopathic Nephrotic Syndrome in Children: An Observational Study
by: Alexandra Mazo, et al.
Published: (2024-03-01)

Immunological risk stratification and tailored minimisation of immunosuppression in renal transplant recipients
by: Mysore K. Phanish, et al.
Published: (2020-03-01)

Rituximab for Children With Difficult-to-Treat Nephrotic Syndrome: Its Effects on Disease Progression and Growth
by: Rezan Topaloğlu, et al.
Published: (2019-07-01)

Mycophenolate mofetil and tacrolimus versus tacrolimus alone for the treatment of idiopathic membranous glomerulonephritis: a randomised controlled trial
by: Aikaterini Nikolopoulou, et al.
Published: (2019-09-01)

A Comparison of Azathioprine and Mycophenolate Mofetil as Adjuvant Drugs in Patients with Pemphigus: A Retrospective Cohort Study
by: Siriorn Sukanjanapong, et al.
Published: (2019-12-01)

Study on Steroid Induced Ocular Findings in Children with Nephrotic Syndrome
by: Vijay Agrawal, et al.
Published: (2017-03-01)

Efficacy of Semiannual Single Fixed Low-Dose Rituximab Therapy in Steroid-Dependent Minimal Change Nephrotic Syndrome: A Case Series
by: Ryosuke Usui, et al.
Published: (2018-10-01)